Articles From: Landec to Present at the Sidoti & Co. Emerging Growth Institutional Investor Forum on January 12, 2015 to Lannett to Present at the 33rd Annual J.P. Morgan Healthcare Conference on January 14


EL SEGUNDO, Calif., Dec.
Sign-up for Landmark Infrastructure Partners LP Announces Closing of Partial Exercise of Over-Allotment Option investment picks
EL SEGUNDO, Calif., Nov.
Sign-up for Landmark Infrastructure Partners LP Prices Initial Public Offering investment picks
EL SEGUNDO, Calif., Nov.
Sign-up for Landmark Infrastructure Partners LP Prices Initial Public Offering investment picks
2014/11/4
In Unprecedented Agreement, Company Must Pay For Future Complications Attributable To Faulty Devices WEST PALM BEACH, Fla.
Sign-up for Landmark National Settlement Reached In Stryker Hip Replacement Lawsuits investment picks
2014/12/1
Chance to win $1,000 Shopping Spree if Initials Match Posted Monograms DODGEVILLE, Wis.
Sign-up for Lands' End #MonogramMonday Campaign Searching for Monogram Matches investment picks
2014/11/24
DODGEVILLE, Wis., Nov.
Sign-up for Lands' End Announces Earnings Release Date for Third Quarter of Fiscal 2014 Financial Results investment picks
2014/12/10
DODGEVILLE, Wis., Dec.
Sign-up for Lands' End Announces Third Quarter of Fiscal 2014 Results investment picks
2014/11/20
It's prime corporate gift shopping season DODGEVILLE, Wis.
Sign-up for Lands' End Business Outfitters Launches its "Great Gift Shop" for Business and Employee Gifts investment picks
2014/12/19
More Than 230 Retail Locations Ready for Last-Minute Gifts DODGEVILLE, Wis.
Sign-up for Lands' End Retail is the Holiday Shopping Procrastination Destination investment picks
2014/10/15
DODGEVILLE, Wis., Oct.
Sign-up for Lands' End Rotates Board Assignments investment picks
2014/11/6
All Students 13+ Could Win State-of-the-Art 3D Printer for their School DODGEVILLE, Wis.
Sign-up for Lands' End School Uniforms launches Make-It! 3D Printer Contest investment picks
2014/11/20
http://media.marketwire.com/attachments/201411/82047_landsend.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1160525&ProfileId=051205&sourceType=1 DODGEVILLE, WI --
Sign-up for Lands' End Survey Predicts a Joyful and Giving Holiday Season investment picks
JACKSONVILLE, Fla.
Sign-up for Landstar Announces Its Mid-Quarter Conference Call investment picks
2014/12/4
JACKSONVILLE, Fla.
Sign-up for Landstar Announces Special Dividend investment picks
JACKSONVILLE, Fla.
Sign-up for Landstar Promotes Stout To Chief Financial Officer investment picks
JACKSONVILLE, Fla.
Sign-up for Landstar To Participate In Raymond James' Global Airline/Transportation Conference investment picks
2014/12/10
COLUMBUS, Ohio , Dec.
Sign-up for Lane Bryant Touches Down in Philadelphia With Exclusive NFL Capsule Collection investment picks
Lannett Company, Inc. (NYSE: LCI) today announced that the U.S. Food and Drug Administration (FDA) has completed its cGMP compliance inspection of Lannett’s wholly owned subsidiary Cody Laboratories, Inc. (Cody), a manufacturer of active pharmaceutical ingredients (APIs) and finished dosage form products.
Sign-up for Lannett Announces Positive FDA Inspection Results investment picks
Lannett Company, Inc. (NYSE: LCI) today announced that it expects to report fiscal 2015 first quarter net sales of approximately $93 million and diluted earnings per share between $0.91 and $0.94. For the prior year first quarter, the company recorded net sales of $45.8 million and net loss attributable to Lannett of $6.0 million, or $0.20 per share, which included a non-recurring pre-tax charge of $20.1 million related to the contract extension with Jerome Stevens Pharmaceuticals, Inc. (JSP). Adjusted net income, which excludes the impact of the JSP contract renewal charge equal to $12.7 million after-tax, was $6.7 million, or $0.22 per diluted share.
Sign-up for Lannett Announces Preliminary Fiscal 2015 First Quarter Net Sales of Approximately $93 Million, EPS between $0.91 and $0.94 investment picks
Lannett Company, Inc. (NYSE: LCI) today announced that Ernest J.
Sign-up for Lannett Announces Retirement of Executive Officer investment picks
Lannett Company, Inc. (NYSE: LCI) today announced the appointment of Michael J.
Sign-up for Lannett Names Michael Bogda as President investment picks
Lannett Company, Inc. (NYSE: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, 2%/0.5%, the therapeutic equivalent to the reference listed drug, Cosopt ® Ophthalmic Solution, 2%/0.5%, of Oak Pharmaceuticals, Inc.. According to IMS, for the year ended October 2014 total sales of Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, 2%/0.5%, at Average Wholesale Price (AWP) were approximately $123 million.
Sign-up for Lannett Receives FDA Approval for Dorzolamide HCL with Timolol investment picks
Lannett Company, Inc. (NYSE: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Letrozole Tablets USP, 2.5 mg, the therapeutic equivalent to the reference listed drug, Femara ® Tablets, 2.5 mg, of Novartis Pharmaceuticals Corporation.
Sign-up for Lannett Receives FDA Approval for Letrozole Tablets USP 2.5 mg investment picks
Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2015 first quarter ended September 30, 2014.
Sign-up for Lannett Reports Net Sales of $93 Million, EPS of $0.94 for Fiscal 2015 First Quarter investment picks
Lannett Company, Inc. (NYSE: LCI) today announced that the company will present at the Credit-Suisse 2014 Healthcare Conference on Tuesday, November 11, 2014, at 4:30 p.m. Mountain Standard Time (6:30 p.m. Eastern Standard Time) at The Biltmore Hotel in Phoenix, AZ.
Sign-up for Lannett to Present at the 2014 Credit-Suisse Healthcare Conference on November 11 investment picks
Lannett Company, Inc. (NYSE: LCI) today announced that the company will present at the 33 rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2015, at 9:30 a.m. Pacific Standard Time at the Westin St.
Sign-up for Lannett to Present at the 33rd Annual J.P. Morgan Healthcare Conference on January 14 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Landec to Present at the Sidoti & Co. Emerging Growth Institutional Investor Forum on January 12, 2015 to Lannett to Present at the 33rd Annual J.P. Morgan Healthcare Conference on January 14
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent